Lung Cancer
Recommended
Price: Low to High
Price: High to Low
Newest
Best Selling
Oysiendx (Osimertinib) 80mg*30 | Laos Generic EGFR TKI | GLT
Bigbear Pharmaceutical (Lao) — affordable osimertinib 80mg generic for EGFR-mutant NSCLC
Osimitib (Osimertinib) 80mg*30 | Laos Alliance Generic | GLT
Laos Alliance Pharmaceutical Group — registered osimertinib 80mg generic (03 L 0953/23)
Rizonib (Crizotinib) 250mg Capsules | DIL Bangladesh Generic Xalkori for ALK+ NSCLC | GLT
Rizonib 250 by Drug International Ltd (DIL), Tongi Gazipur — affordable crizotinib generic from Bangladesh
Selpercatinib (Sepadx) 40mg — RET-Driven Cancer | GLT
Generic selpercatinib (Bigbear) for RET-driven lung and thyroid cancer
Selpercatinib (LuciSel) 40mg — RET-Driven Cancer | GLT
Generic selpercatinib (Lucius) for RET-driven lung and thyroid cancer
Selpercatinib (Selpacta) 40mg/80mg — RET-Driven Cancer | GLT
Affordable generic selpercatinib (Ziska) for RET-driven lung and thyroid cancer
Selpercatinib (PHOSELP) 40mg — RET-Driven Cancer | GLT
Generic selpercatinib (Pharma No.2, Laos) for RET-driven lung and thyroid cancer
Selpercatinib (Selcaxen) 40mg — RET-Driven Cancer | GLT
Affordable generic selpercatinib (Everest) for RET-driven lung and thyroid cancer
Selpercatinib (Retevmo) — RET-Driven Lung & Thyroid Cancer | GLT
FDA-approved selective RET kinase inhibitor for RET fusion-positive NSCLC and thyroid cancer
Lumakras (Sotorasib) 120mg Tablets | KRAS G12C NSCLC & mCRC | Amgen US | GLT
Amgen's first-in-class KRAS G12C inhibitor, FDA-approved for KRAS G12C-mutated NSCLC and mCRC.
Lumakras (Sotorasib) 120mg Tablets | KRAS G12C NSCLC & mCRC | Amgen Boao China | GLT
Amgen's first-in-class KRAS G12C inhibitor, supplied from the Boao (Hainan) medical pilot zone — first...
PHOSOTOR (Sotorasib) 120mg*112's | Generic KRAS G12C Inhibitor | Pharma 2 Vientiane | GLT
Generic sotorasib (KRAS G12C inhibitor) by Pharma 2 Vientiane (Laos) — an affordable alternative to...
Sotoxen (Sotorasib) 120mg*56's | Generic KRAS G12C Inhibitor | Everest Pharmaceuticals Ltd. | GLT
Generic sotorasib (KRAS G12C inhibitor) by Everest Pharmaceuticals Ltd. (Bangladesh) — an affordable alternative to...
Sotoraib (Sotorasib) 120mg*120's | Generic KRAS G12C Inhibitor | Trans Continental Life Science & Pharmaceuticals (Tlph) | GLT
Generic sotorasib (KRAS G12C inhibitor) by Trans Continental Life Science & Pharmaceuticals (Tlph) (Laos) —...
Sotakras (Sotorasib) 120mg*56's | Generic KRAS G12C Inhibitor | Ziska Pharmaceuticals Ltd. | GLT
Generic sotorasib (KRAS G12C inhibitor) by Ziska Pharmaceuticals Ltd. (Bangladesh) — an affordable alternative to...
Sotoldx (Sotorasib) 120mg*56's | Generic KRAS G12C Inhibitor | BigBear Pharmaceutical Co., Ltd. | GLT
Generic sotorasib (KRAS G12C inhibitor) by BigBear Pharmaceutical Co., Ltd. (Laos) — an affordable alternative...
LuciSot (Sotorasib) 120mg*56's | Generic KRAS G12C Inhibitor | Lucius Pharmaceuticals (Lao) Co., Ltd. | GLT
Generic sotorasib (KRAS G12C inhibitor) by Lucius Pharmaceuticals (Lao) Co., Ltd. (Laos) — an affordable...
Sotocare (Sotorasib) 120mg*56's | Generic KRAS G12C Inhibitor | ElementoPharma Co., Ltd. | GLT
Generic sotorasib (KRAS G12C inhibitor) by ElementoPharma Co., Ltd. (Laos) — an affordable alternative to...
Mekinist (Trametinib) 2mg Tablets | MEK Inhibitor | Novartis Switzerland | GLT
Novartis's first-in-class MEK inhibitor for BRAF-mutated melanoma and NSCLC, supplied for Switzerland.
Mekinist (Trametinib) 2mg Tablets | MEK Inhibitor | Novartis India | GLT
Novartis's first-in-class MEK inhibitor for BRAF-mutated melanoma and NSCLC, supplied for India.
Sort
- Recommended
- Price: Low to High
- Price: High to Low
- Newest
- Best Selling